Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-U3283
Digital Therapeutics Market is estimated to value over CAGR of over 26.5% during the forecast period 2022 to 2028. Rise in the number of initiatives by government bodies for precautionary healthcare, advancements in technology in telemedicine and mobile healthcare, escalating investments by venture capitalists in digital therapeutics and a wide range of advantages of digital therapeutics like user friendliness, induction of behavioural change, improvements in the drug compliance and patient convenience are some of the factors responsible for the digital therapeutics market growth. However, a dearth of access and awareness regarding digital therapeutics programs in emerging nations, concerns over privacy of patient data, reluctance from traditional healthcare service providers in adopting digital therapeutics, and payment models that are unstable and unreliable are some factors that can possibly impede the growth of the market substantially. With a rise in the number of smartphone users, the adoption of digital therapeutics will be seamless producing multiple lucrative opportunities for market growth. Furthermore, digital therapeutics provide easy patient monitoring and tracking their vitals without any intervention. Such non-interventional and discrete service has persuaded people to accept a healthy and fit lifestyle for improving their physical well-being, thereby producing more growth opportunities for the market. Market Segmentation: By Sales Channel • B2C o Patients o Caregivers • B2B o Providers o Payers o Employers o Pharmaceutical Companies o Other Buyers By Application • Preventive Applications o Prediabetes o Obesity o Nutrition o Lifestyle Management o Other Preventive Applications • Treatment/Care Related Applications o Diabetes o CNS Disorders o Chronic Respiratory Disorders o Musculoskeletal Disorders o Other Treatment/Care-related Applications By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is categorised into sales channel, application and region. The sales channel segment is fragmented into B2C and B2B. The business-to-business segment is anticipated to hold the largest digital therapeutics market share and this can be attributed to increased awareness among payers, employers and providers regarding the advantages offered by digital therapeutics and the reduction in healthcare expenditure with its usage. In addition, there has been a rising preference of pharma companies in integrating their drug products with digital therapeutics, resulting in the proliferation of the segment. The application segment is bifurcated into preventive applications and treatment/care related applications. The diabetes sub-segment from the care related application segment is poised to lead the market in terms of generating revenue and this can be credited to the rising prevalence of diabetes. Additionally, the increased insistence for healthcare services that are cost effective shall people the proliferation of the market. Conversely, the obesity segment is anticipated to grow at a substantial rate during the forecasted timeframe and this can be credited to a rise in the number of overweight people, increased prevalence of appalling diseases like arthritis, cardiovascular disease with the occurrence of obesity. Moreover, an improves access to digital therapeutics shall assist the patients in maintaining their diets and in tracking regular physical activities and health data. For instance, Oxil in 2017 launched a mobile application for tackling obesity issues amongst the young population. The development of such applications shall bolster the augmentation of the market. Regional Analysis: The North America region is expected to lead the market and this is mainly due to an escalation in the influx of emerging players, improving reimbursement structure for digital therapeutics and rise in the number of initiatives undertaken by government bodies. Competitive Landscape: The prominent players of the market are Noom, Livongo Health, WellDoc, Pear Therapeutics, Omada Health, Proteus Digital Health, Propeller Health, Akili Interactive Labs, Better Therapeutics, Happify, Kaia Health, Mango Health, Click Therapeutics, Canary Health, Wellthy Therapeutics, Cognoa, Ayogo Health, Mindstrong Health, 2Morrow, Ginger. Omada Health is one of the leading players in the digital therapeutics sector. Their digital prediabetes program named ‘Prevent’ has attracted multiple venture capital investments. They received over USD 70 million from its investors for developing digital healthcare programs emphasizing on preventing appalling conditions. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global digital therapeutics market by sales channel, by application and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Rise in the number of initiatives by government bodies for precautionary healthcare, advancements in technology in telemedicine and mobile healthcare, escalating investments by venture capitalists in digital therapeutics and a wide range of advantages of digital therapeutics like user friendliness, induction of behavioural change, improvements in the drug compliance and patient convenience are some of the factors responsible for the digital therapeutics market growth. However, a dearth of access and awareness regarding digital therapeutics programs in emerging nations, concerns over privacy of patient data, reluctance from traditional healthcare service providers in adopting digital therapeutics, and payment models that are unstable and unreliable are some factors that can possibly impede the growth of the market substantially. With a rise in the number of smartphone users, the adoption of digital therapeutics will be seamless producing multiple lucrative opportunities for market growth. Furthermore, digital therapeutics provide easy patient monitoring and tracking their vitals without any intervention. Such non-interventional and discrete service has persuaded people to accept a healthy and fit lifestyle for improving their physical well-being, thereby producing more growth opportunities for the market.
Market Segmentation:
By Sales Channel • B2C o Patients o Caregivers • B2B o Providers o Payers o Employers o Pharmaceutical Companies o Other Buyers
By Application • Preventive Applications o Prediabetes o Obesity o Nutrition o Lifestyle Management o Other Preventive Applications • Treatment/Care Related Applications o Diabetes o CNS Disorders o Chronic Respiratory Disorders o Musculoskeletal Disorders o Other Treatment/Care-related Applications
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is categorised into sales channel, application and region. The sales channel segment is fragmented into B2C and B2B. The business-to-business segment is anticipated to hold the largest digital therapeutics market share and this can be attributed to increased awareness among payers, employers and providers regarding the advantages offered by digital therapeutics and the reduction in healthcare expenditure with its usage. In addition, there has been a rising preference of pharma companies in integrating their drug products with digital therapeutics, resulting in the proliferation of the segment. The application segment is bifurcated into preventive applications and treatment/care related applications. The diabetes sub-segment from the care related application segment is poised to lead the market in terms of generating revenue and this can be credited to the rising prevalence of diabetes. Additionally, the increased insistence for healthcare services that are cost effective shall people the proliferation of the market. Conversely, the obesity segment is anticipated to grow at a substantial rate during the forecasted timeframe and this can be credited to a rise in the number of overweight people, increased prevalence of appalling diseases like arthritis, cardiovascular disease with the occurrence of obesity. Moreover, an improves access to digital therapeutics shall assist the patients in maintaining their diets and in tracking regular physical activities and health data. For instance, Oxil in 2017 launched a mobile application for tackling obesity issues amongst the young population. The development of such applications shall bolster the augmentation of the market.
Regional Analysis:
The North America region is expected to lead the market and this is mainly due to an escalation in the influx of emerging players, improving reimbursement structure for digital therapeutics and rise in the number of initiatives undertaken by government bodies.
Competitive Landscape:
The prominent players of the market are Noom, Livongo Health, WellDoc, Pear Therapeutics, Omada Health, Proteus Digital Health, Propeller Health, Akili Interactive Labs, Better Therapeutics, Happify, Kaia Health, Mango Health, Click Therapeutics, Canary Health, Wellthy Therapeutics, Cognoa, Ayogo Health, Mindstrong Health, 2Morrow, Ginger. Omada Health is one of the leading players in the digital therapeutics sector. Their digital prediabetes program named ‘Prevent’ has attracted multiple venture capital investments. They received over USD 70 million from its investors for developing digital healthcare programs emphasizing on preventing appalling conditions.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global digital therapeutics market by sales channel, by application and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Digital Therapeutics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Digital Therapeutics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Digital Therapeutics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Digital Therapeutics Market, By Sales Channel Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. B2C 7.1.1. Patients 7.1.2. Caregivers 7.2. B2B 7.2.1. Providers 7.2.2. Payers 7.2.3. Employers 7.2.4. Pharmaceutical Companies 7.2.5. Other Buyers 8. Digital Therapeutics Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Preventive Applications 8.1.1 Prediabetes 8.1.2 Obesity 8.1.3 Nutrition 8.1.4 Lifestyle Management 8.1.5 Other Preventive Applications 8.2. Treatment/Care Related Applications 8.2.1. Diabetes 8.2.2. CNS Disorder 8.2.3. Chronic Respiratory Disorders 8.2.4. Musculoskeletal Disorders 8.2.5. Other Treatment/Care-related Applications 9. North America Digital Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028 10. Latin America Digital Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028 11. Europe Digital Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028 12. Asia Pacific Digital Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Noom 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Livongo Health 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Omada Health 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. WellDoc 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Pear Therapeutics 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Proteus Digital Health 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Propeller Health 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Akili Interactive Labs 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Better Therapeutics 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10.Happify 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11.Kaia Health 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12.Mango Health 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13.Click Therapeutics 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14.Canary Health 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15.Wellthy Therapeutics 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16.Cognoa 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17.Ayogo Health 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18.Mindstrong Health 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19.2Morrow 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 15.20.Ginger 15.20.1. Company Overview 15.20.2. Product Portfolio 15.20.3. SWOT Analysis 15.20.4. Financial Overview 15.20.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Digital Therapeutics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Digital Therapeutics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Digital Therapeutics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Digital Therapeutics Market, By Sales Channel Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. B2C 7.1.1. Patients 7.1.2. Caregivers 7.2. B2B 7.2.1. Providers 7.2.2. Payers 7.2.3. Employers 7.2.4. Pharmaceutical Companies 7.2.5. Other Buyers
8. Digital Therapeutics Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Preventive Applications 8.1.1 Prediabetes 8.1.2 Obesity 8.1.3 Nutrition 8.1.4 Lifestyle Management 8.1.5 Other Preventive Applications 8.2. Treatment/Care Related Applications 8.2.1. Diabetes 8.2.2. CNS Disorder 8.2.3. Chronic Respiratory Disorders 8.2.4. Musculoskeletal Disorders 8.2.5. Other Treatment/Care-related Applications
9. North America Digital Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028
10. Latin America Digital Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028
11. Europe Digital Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028
12. Asia Pacific Digital Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Noom 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Livongo Health 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Omada Health 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. WellDoc 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Pear Therapeutics 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Proteus Digital Health 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Propeller Health 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Akili Interactive Labs 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Better Therapeutics 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10.Happify 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11.Kaia Health 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12.Mango Health 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13.Click Therapeutics 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14.Canary Health 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15.Wellthy Therapeutics 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16.Cognoa 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17.Ayogo Health 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18.Mindstrong Health 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19.2Morrow 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 15.20.Ginger 15.20.1. Company Overview 15.20.2. Product Portfolio 15.20.3. SWOT Analysis 15.20.4. Financial Overview 15.20.5. Strategic Overview
16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics